All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

The Supreme Court's overturning of Roe v. Wade may lead to increased investment in women's health and related tech.

What they're saying: “This is going to drive innovation by necessity,” Goodwin Procter health care attorney Delphine O’Rourke tells Axios.

O’Rourke adds that she's already gotten calls from folks pondering a fund dedicated to women’s health investing and innovation.

Zoom in: VC-backed DTC startups like Tia, Choix, Hey Jane, AidAccess and Just the Pill, which already prescribe abortion pills, already are seeing demand surge, per Fierce Healthcare.

Kelso and Juggernaut, the two PE shops behind the top-selling morning-after pills, Plan B, could see a surge in profits as women stock up on emergency contraception pills. Particularly given Justice Clarence Thomas' suggestion that rulings like Griswold (the right to contraception) be reevaluated.

O’Rourke also expects more investment into safe-haven states like California. If you have a fertility clinic and “can absorb those patients that will be traveling, that’s an opportunity,” she notes, adding that clinics also are navigating how to ship embryos across state borders. 

Other investment areas O’Rourke cites include virtual mental health, where there could emerge a spike in demand for services tailored to postpartum depression, startups that look at the quality of embryos, and education offerings for health care companies seeking to navigate the new legal landscape. 

Plus, technology around security and privacy that wraps around services you're already invested in. 

Yes, and: Don’t assume because it’s not directly touching women’s health that there won’t be an impact, O’Rourke says. 

For example, if you’re providing primary care for women who are on Medicaid and they are concerned about the state law, they aren’t going to come and see you. “It’s a chilling effect,” O’Rourke says. 

The bottom line: “[Access to women’s health] is a super unmet need in a large market, and rational investors see that as an opportunity,” says SVB Securities banker Sasha Kelemen. “It’s a very personal mission. The best companies will still transcend."

How Roe could trigger investment

The fallout of the ruling could ignite more investment in innovation to improve access to women's health.

Illustration of a caduceus turning into a gavel.

Health tech deals

The Supreme Court&#x27;s overturning of Roe v. Wade may lead to increased investment in women&#x27;s health and related tech.What they&#x27;re saying: “This is going to drive innovation by necessity,” Goodwin Procter health care attorney Delphine O’Rourke tells Axios.

How Roe could trigger investment

What to read next